Biomanufacturing Training and Education Center Rises at North Carolina State - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Biomanufacturing Training and Education Center Rises at North Carolina State


ePT--the Electronic Newsletter of Pharmaceutical Technology

Untitled Document

At the end of July, North Carolina State University (Raleigh, NC, www.ncsu.edu) celebrated the completion of the steel skeleton of its new Biomanufacturing Training and Education Center (BTEC, Raleigh, NC, www.engr.ncsu.edu/btec) with a topping-out ceremony attended by the construction workers and leaders from BioNetwork, BTEC, and the NC State Facilities Division.

BTEC is the result of a collaboration between local biomanufacturing-industry leaders and university faculty who had a strong interest in biotechnology and bioprocessing. The venture received support from the state government as well as from local universities, industry, and community colleges and was made possible by a substantial contribution from The Golden LEAF Foundation, a nonprofit organization based in Rocky Mount, North Carolina. This group is dedicated to helping North Carolinians make the transition from a tobacco-dependent economy by making investments that will positively affect the state’s long-term economic advancement.

When completed, the 86,000-ft2 facility will house a fully equipped laboratory training space and classrooms and will offer instruction in cell and protein harvest and recovery, protein purification, product characterization, and sterile filling and packaging. It will be the largest pilot-scale protein manufacturing facility in academia in the United States.

“I believe [BTEC is] unique on two counts,” says Peter Kilpatrick, PhD, BTEC’s director. "It's the largest CGMP protein manufacturing lab in a university in the country and the only CGMP facility that will be used exclusively for education and not contract manufacturing."

As work on the building moves forward, Kilpatrick is concentrating on recruiting faculty and staff. The search includes current NC State faculty members who have research or teaching interests related to biomanufacturing as well as new PhDs, faculty from other universities, and members of the biomanufacturing industry.

“It is a unique facility, so we want to develop unique programs and unique people,” says Kilpatrick.  “We want to develop a reputation as being the preferred place in the world to obtain biomanufacturing and bioprocessing science and engineering education.”

BTEC is expected to be completed and ready for process validation in May or June of 2007.

ADVERTISEMENT

RELATED CONTENT
Biomanufacturing Training and Education Center Rises at North Carolina State
blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
15%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here